• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Self-measured blood pressure monitoring lowers pressures compared to typical clinical monitoring

bys25qthea
August 6, 2013
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Slowdown in healthcare costs linked to economic and clinical factors
Share on FacebookShare on Twitter

Image: PD 

1. At 6 months, self-measured blood pressure (SMBP) monitoring resulted in a lower BP compared to BP monitoring at a clinic. 

2.  The evidence for additional supportive measures used in conjunction with SMBP monitoring (such as educational resources, counseling and behavioral management) is limited and fails to show a significant lowering of blood pressure when compared with SMBP monitoring alone.  

Evidence Rating Level: 1 (Excellent)       

Study Rundown: Clinical guidelines recommend SMBP monitoring in the management of hypertension; however, there are few evidence-based evaluations for this approach.  This systemic review of fifty-two prospective comparative studies suggested that SMBP is associated with a significant improvement in blood pressure as compared with usual monitoring in a clinical setting at six months (mean net reduction -3.9 mmHg systolic and -2.4 mmHg diastolic).  The study also looked at the effect of additional supports used with SMBP.  Although SMBP monitoring with additional supports was associated with a significant improvement in blood pressure at 12 months compared to usual monitoring, the study failed to show a benefit of these supports used with SMBP monitoring when compared to SMBP monitoring alone.  Evidence for blood pressure control beyond 12 months and other clinical outcomes (such as death and cardiovascular events) were of limited quality.  Although this is the largest systematic review of SMBP monitoring to date, the results of this study need to be further validated in larger randomized trials to determine long-term effectiveness, sustainability of results, and whether the results can be generalized on other populations.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

A health coaching intervention may improve blood pressure control in postpartum women

2 Minute Medicine Rewind August 10, 2026

Amazon Health Services expands generative artificial intelligence assistant to all United States customers

Relevant Reading: The Role of Home Blood Pressure Telemonitoring in Managing Hypertensive Populations

In-Depth [systematic review]: This review sought to determine the effect of SMBP monitoring with and without additional care compared to usual care.  Additional care included support such as:  telemonitoring, educational materials, behavioral management, and antihypertensive medication management.  Usual care was defined as any BP monitoring in a clinic.  52 studies were identified from MEDLINE and Cochrane Reviews and were graded A, B, or C in terms of quality by expert reviewers.  Generally, participants were Caucasian and were characterized as having uncomplicated hypertension and being without an acute disease state.   When comparing SMBP monitoring to usual care, a lower BP was observed at 6 months (mean net reduction -3.9 mmHg systolic and -2.4 mmHg diastolic; p<0.001).  However, significance was not seen at 12 months (-1.5 mmHg systolic and -0.8 mmHg diastolic).  When comparing SMBP monitoring with additional support vs. usual care, a lower BP was still significant at 12 months (Ranging between -3.4 to -8.9 mmHg systolic and -3.9 to -4.4 mmHg diastolic).  However, in the latter comparison, the authors did not perform a meta-analysis.  Instead, they opted to only use the highest “A” quality trials (6) which all showed statistically significant mean net reduction in systolic and diastolic BP.

The study also compared SMBP monitoring with additional supports to SMBP alone.  Only weak evidence was available for this comparison, and the study failure to show a significant difference. Clinical outcomes, surrogate outcomes, patient reported outcomes, and health care utilization were also looked at in the study, but the evidence available was limited and inconsistent.

By Adam Whittington and Aimee Li, MD

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: blood pressurediastolicprimary caresystolic
Previous Post

Lack of mucosal healing in celiac disease linked with increased risk of lymphoma

Next Post

Many smokeless tobacco users also smoke

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Patient-reported feedback may not improve health-related quality of life
Pharma

Amazon Health Services expands generative artificial intelligence assistant to all United States customers

September 4, 2026
Chronic Disease

Patient and provider characteristics associated with difficult clinical encounters

January 12, 2026
Next Post
Smokeless tobacco use in children has not changed

Many smokeless tobacco users also smoke

A framework for mental health care response after disasters

A framework for mental health care response after disasters

Naltrexone reduces drinking in alcoholics with post-traumatic stress disorder

Naltrexone reduces drinking in alcoholics with post-traumatic stress disorder

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Video mental health care may have clinical advantages versus phone or in-person visits
  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.